title: Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.
authors.affiliation: Department of Surgery, Catholic University, Largo A. Gemelli 8, Rome 00168, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Citterio
authors.forename: P
authors.initials: P
authors.lastname: Rigotti
authors.forename: M C
authors.initials: MC
authors.lastname: Scatà
authors.forename: J
authors.initials: J
authors.lastname: Romagnoli
authors.forename: N
authors.initials: N
authors.lastname: Baldan
authors.forename: F
authors.initials: F
authors.lastname: Marchini
authors.forename: M
authors.initials: M
authors.lastname: Castagneto
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D005060:Europe; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D018579:Patient Selection; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011507:Proteinuria; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003404:Creatinine; D009173:Mycophenolic Acid; D011241:Prednisone; D016559:Tacrolimus